These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6110238)

  • 1. [The computerized electroencephalogram in evaluating the action of vasoactive and eumetabolic drugs in chronic cerebrovascular disorders].
    Martucci N; Bocola V; Mearelli S; Agnoli A
    Riv Neurol; 1980; 50(2):73-97. PubMed ID: 6110238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short-term administration of cytidine, uridine and levoglutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease.
    Manna V; Martucci N
    Int J Clin Pharmacol Res; 1988; 8(3):199-210. PubMed ID: 3403106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
    Berdichevskiĭ MIa; Onopchenko NV; Dronnikova IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1178-81. PubMed ID: 3673412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of complamin in complex rehabilitation treatment of post-stroke patients of older age groups].
    Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA
    Vrach Delo; 1978 Dec; (12):47-50. PubMed ID: 741723
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of komplamin and nikoshpan on brain circulation and metabolism in the postischemic period].
    Nagornaia GV; Gaevyĭ MD
    Farmakol Toksikol; 1988; 51(1):38-41. PubMed ID: 3360105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of complamin and seduxen in the correction of hemodynamic disorders of epileptic children and adolescents].
    Bulakhova LA; Martyniuk VIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(6):858-62. PubMed ID: 3630497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical therapy of cerebral ischemia. Vasoactive and eumetabolic therapy.
    Strano A; Pinto A; Davì G; Novo S; Riolo F
    Eur Neurol; 1978; 17 Suppl 1():144-9. PubMed ID: 753630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Learning and concentration abilities of elderly patients with the depressive syndrome in cerebrovascular circulation disorders].
    Haupt R; Isermann H
    Nervenarzt; 1976 Apr; 47(4):269-71. PubMed ID: 1272488
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
    Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B; Molnár L; Demeter J; Túry F
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of some non vasoactive nucleosides (cytidine and uridine) in therapy of cerebral vascular diseases].
    Sanguineti I; Zerbi D
    Minerva Med; 1965 Oct; 56(79):3352-61. PubMed ID: 5846622
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
    Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of komplamin in chronic ischemic heart disease].
    Serkova VK; Mikunis RI
    Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.